Bio Key International (BKYI) Amortization of Deferred Charges (2010 - 2026)

Bio Key International has reported Amortization of Deferred Charges for 10 years, with the latest figure at $20833.0 in Q1 2026.

• Quarterly Amortization of Deferred Charges fell 65.28% year-over-year to $20833.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13748.0 (down 110.93% YoY) and the FY2025 annual result came in at $25419.0, down 68.03% from the prior year.
• Amortization of Deferred Charges advanced to $20833.0 in Q1 2026 per BKYI's latest filing, from -$154581.0 in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $67450.0 in Q4 2022 and troughed at -$154581.0 in Q4 2025.
• A 5-year average of $17570.4 and a median of $43604.0 in 2022 frame the typical range for Amortization of Deferred Charges.
• The sharpest annual moves came in 2023 and 2025: Amortization of Deferred Charges jumped 1189.34% in 2023, then slumped 1095.95% in 2025.
• Over 5 years, Amortization of Deferred Charges stood at $67450.0 in 2022, then plunged by 267.15% to -$112745.0 in 2023, then surged by 113.77% to $15521.0 in 2024, then plunged by 1095.95% to -$154581.0 in 2025, then soared by 113.48% to $20833.0 in 2026.
• According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $20833.0, -$154581.0, and $60000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.